Skip to content
Screener

Xtant Medical Holdings XTNT Q1 2026 Annual earnings

Reported May 13, 2026 · Before market open

Revenue$20.9MBeat by $719.7K
EPS-$0.02Miss by $0.01
Revenue estimate$20.2M
EPS estimate-$0.02

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$25.5M
EPS estimate-$0.03

Financials

Q1 2026

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02—

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$78.14M+19.6%
Enterprise value$80.98M-2.4%
P/E42.8×—
P/S0.6×+0.1×

Profitability

See full
Gross margin62.3%+4.2pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Segments

By product

See full
Orthobiologics$15.6M-13.6%
Spinal Implant$5.3M-52.9%

FAQ

When did Xtant Medical Holdings report Q1 2026 earnings?
Xtant Medical Holdings (XTNT) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Xtant Medical Holdings's Q1 2026 revenue and EPS?
Xtant Medical Holdings reported revenue of $20.9M and eps of $-0.02 for Q1 2026.
Did Xtant Medical Holdings beat estimates in Q1 2026?
Revenue beat the consensus estimate of $20.2M by $719.7K. EPS missed the consensus estimate of $-0.01 by $0.01.
How did Xtant Medical Holdings's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 36.5% from $32.9M a year earlier.
Where can I find Xtant Medical Holdings's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-022600) and the 10-K periodic report (0001493152-26-013792) directly on SEC EDGAR. The filing index links above go to sec.gov.